Identification of sensitive outcome measures / evaluation tools for clinical trials in LGMDR12

A Belgian natural history study evaluated the sensitivity of walking tests, MRC score and isokinetic dynamometer in 24 walking patients with ANO5-related LGMD R12 over two years. These results are compared with quantitative MRI examination of the thigh muscles.

The investigators show that :

  • Possible muscle changes in patients with early or late stage muscle degeneration are not detected over the two years of follow-up, regardless of the test method.
  • The fat fraction measured by MRI of the muscles of patients who were enrolled in the study at an “intermediate” stage of the disease (fat replacement between 20% and 70%) shows a detectable increase one year after the start of the follow-up.
  • Muscle strength measured by isokinetic dynamometer shows a decrease in the thighs one year after the start of follow-up, which makes it a good measurement tool for clinical trials.
  • Walking tests and the MRC score do not detect any significant change in muscle function, even after two years of follow-up.
  • Fat replacement in thigh muscles is not homogeneous within the same muscle, indicating the need to assess the whole muscle.

 

Prospective Natural History Study in 24 Adult Patients With LGMDR12 Over 2 Years’ Follow-up: Quantitative MRI and Clinical Outcome Measures. De Wel, B., Huysmans, L., Peeters, R. et al. Neurology. 2022.